Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection
Clinical trial NCT06585150 · TERMINATED
Trial details
- NCT number
- NCT06585150
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-14
- Primary completion
- 2025-05-08
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.